Breakthrough Cancer Therapy Halts Tumor Growth
A breakthrough therapy targets the RAS-PI3K interaction to halt tumor growth while sparing healthy cells.
A breakthrough therapy targets the RAS-PI3K interaction to halt tumor growth while sparing healthy cells.
Diane Davis's journey from a grim cancer diagnosis to successful immunotherapy guided by Lynch syndrome.
